146 related articles for article (PubMed ID: 31927745)
1. Vogt-Koyanagi-Harada syndrome: importance of early treatment.
Radic B; Vukojevic N; Petelin Gadze Z; Dapic Ivancic B; Barun B
Acta Neurol Belg; 2020 Oct; 120(5):1217-1219. PubMed ID: 31927745
[No Abstract] [Full Text] [Related]
2. [Long-term course of immunosuppressive therapy of Vogt-Koyanagi-Harada syndrome].
Wand K; Abraham S; Loos D; Stumpfe S; Lohmann C; Maier M; Feucht N
Ophthalmologe; 2015 Oct; 112(10):857-60. PubMed ID: 25680347
[TBL] [Abstract][Full Text] [Related]
3. Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.
Agarwal M; Ganesh SK; Biswas J
Ocul Immunol Inflamm; 2006 Dec; 14(6):333-9. PubMed ID: 17162603
[TBL] [Abstract][Full Text] [Related]
4. [Sensorineural hearing loss evolution in Vogt-Koyanagi-Harada syndrome].
Rodríguez Rivera V; Garrigues HP; Gallego Pinazo R
Acta Otorrinolaringol Esp; 2011; 62(6):465-8. PubMed ID: 21167466
[TBL] [Abstract][Full Text] [Related]
5. Vogt-Koyanagi-Harada disease: study of 14 cases.
Espinosa-Barberi G; Reyes Rodríguez MÁ; Francisco Hernández F
Med Clin (Barc); 2019 Feb; 152(4):159-160. PubMed ID: 29731134
[No Abstract] [Full Text] [Related]
6. Vogt-Koyanagi-Harada syndrome associated with bilateral serous macular detachments responsive to immunomodulatory therapy.
Gallagher MJ; Yilmaz T; Foster CS
Ophthalmic Surg Lasers Imaging; 2009; 40(3):345-7. PubMed ID: 19485308
[No Abstract] [Full Text] [Related]
7. [Vogt-Koyanagi-Harada disease associated with interferon-alpha and ribavirin therapy for chronic hepatitis C infection].
Chebil A; Kort F; Bouraoui R; Youssef NB; El Matri L
J Fr Ophtalmol; 2010 Mar; 33(3):185-8. PubMed ID: 20172621
[TBL] [Abstract][Full Text] [Related]
8. Vogt-Koyanagi-Harada disease presenting initially as aseptic meningoencephalitis.
Kamondi A; Szegedi A; Papp A; Seres A; Szirmai I
Eur J Neurol; 2000 Nov; 7(6):719-22. PubMed ID: 11136362
[TBL] [Abstract][Full Text] [Related]
9. Melanin-laden macrophages in the CSF to diagnose Vogt-Koyanagi-Harada simulating ocular syphilis.
Kim LA; Khurana RN; Parikh JG; Rao NA
Ocul Immunol Inflamm; 2008; 16(1):59-61. PubMed ID: 18379946
[TBL] [Abstract][Full Text] [Related]
10. Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.
Caso F; Rigante D; Vitale A; Costa L; Bascherini V; Latronico E; Franceschini R; Cantarini L
Clin Rheumatol; 2015 Oct; 34(10):1817-20. PubMed ID: 25224382
[TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha2a and Vogt-Koyanagi-Harada disease: a double-edged sword?
Touitou V; Sene D; Fardeau C; Boutin TH; Duhaut P; Piette JC; LeHoang P; Cacoub P; Bodaghi B
Int Ophthalmol; 2007; 27(2-3):211-5. PubMed ID: 17318324
[TBL] [Abstract][Full Text] [Related]
12. [Incomplete Vogt-Koyanagi-Harada syndrome associated with HLA DRB1*01 in a 4-year-old child: case report].
Lucena DR; Paula JS; Silva GC; Rodrigues Mde L
Arq Bras Oftalmol; 2007; 70(2):340-2. PubMed ID: 17589710
[TBL] [Abstract][Full Text] [Related]
13. [Vogt-Koyanagi-Harada syndrome. Eight cases].
Alaoui FZ; Benamour S; El Kabli H; Amraoui A
Rev Med Interne; 2007 Apr; 28(4):250-4. PubMed ID: 17350144
[TBL] [Abstract][Full Text] [Related]
14. Vogt-Koyanagi-Harada syndrome: what neurologists need to know.
Lueck CJ
Pract Neurol; 2019 Aug; 19(4):278-281. PubMed ID: 30890585
[No Abstract] [Full Text] [Related]
15. Treatment of Vogt-Koyanagi-Harada disease by corticosteroids and immunosuppressive agents.
Rao NA
Ocul Immunol Inflamm; 2006 Apr; 14(2):71-2. PubMed ID: 16597535
[No Abstract] [Full Text] [Related]
16. Vogt-Koyanagi-Harada syndrome.
Hammer H; Janáky M; Süveges I
Acta Ophthalmol (Copenh); 1993 Oct; 71(5):711-3. PubMed ID: 8109221
[TBL] [Abstract][Full Text] [Related]
17. Vogt-Koyanagi-Harada disease: diagnosis and treatments update.
Bordaberry MF
Curr Opin Ophthalmol; 2010 Nov; 21(6):430-5. PubMed ID: 20829689
[TBL] [Abstract][Full Text] [Related]
18. Reappraisal of the management of Vogt-Koyanagi-Harada disease: sunset glow fundus is no more a fatality.
Herbort CP; Abu El Asrar AM; Yamamoto JH; Pavésio CE; Gupta V; Khairallah M; Tugal-Tutkun I; Soheilian M; Takeuchi M; Papadia M
Int Ophthalmol; 2017 Dec; 37(6):1383-1395. PubMed ID: 27844182
[TBL] [Abstract][Full Text] [Related]
19. Rituximab for sight-threatening refractory pediatric Vogt-Koyanagi-Harada disease.
Umran RMR; Shukur ZYH
Mod Rheumatol; 2018 Jan; 28(1):197-199. PubMed ID: 26154298
[TBL] [Abstract][Full Text] [Related]
20. Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease.
Sasamoto Y; Ohno S; Matsuda H
Ophthalmologica; 1990; 201(3):162-7. PubMed ID: 2089358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
